Gufic BioSciences Ltd

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 01 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Sell to Strong Sell as of 17 Nov 2025. Despite a modest weekly price gain, the stock’s broader technical indicators signal increasing bearish pressure, reflecting challenges in sustaining upward momentum amid sector headwinds and market volatility.

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent downgrade to a Strong Sell rating with a Mojo Score of 28.0, the stock’s technical indicators reveal nuanced trends that investors should carefully analyse amid ongoing market volatility.

Gufic BioSciences Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent performance, combined with deteriorating moving averages and mixed signals from momentum oscillators, suggests increasing downside pressure amid a challenging market environment.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Gufic BioSciences Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a 4.74% rise in the stock price to ₹300.50 on 9 Apr 2026, the company’s overall technical and fundamental signals suggest caution for investors amid mixed momentum and sector challenges.

Despite a broader market rally, Gufic BioSciences Ltd has plunged to a fresh 52-week low of Rs 267.5 on 30 Mar 2026, extending its recent downtrend amid persistent financial headwinds and valuation concerns.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 March 2026, providing investors with the latest insights into the company’s performance and outlook.

The Sensex climbed 2.28% on 25 Mar 2026, yet Gufic BioSciences Ltd outpaced the broader market with a 7.25% gain, reaching an intraday high of Rs 301. This 4.73 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector's 2.21% advance highlights a distinctly stock-specific rally.

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with bearish trends intensifying across key indicators. Despite some bullish signals on shorter-term charts, the overall technical outlook has deteriorated, prompting a downgrade in its Mojo Grade to Strong Sell as of 17 Nov 2025.

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent upgrade from a Sell to a Strong Sell rating by MarketsMOJO on 17 Nov 2025, the stock’s price action and technical indicators reveal a cautious outlook for investors navigating this evolving landscape.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 07 March 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.268.65 today, marking a significant point in its recent price trajectory. The stock has been on a declining path for the past three days, cumulatively losing 2.15% in returns, reflecting ongoing pressures within the company’s performance metrics and market valuation.

Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.268.65 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors.

Shares of Gufic BioSciences Ltd have declined to a fresh 52-week low, touching an intraday low of ₹274.85, marking a significant milestone in the stock’s ongoing downward trajectory. This new low comes amid a broader market decline and reflects persistent pressures on the company’s financial performance and valuation metrics.

Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.273.1 today, marking a significant decline amid a broader market downturn. The stock’s recent performance reflects ongoing pressures, with the share price falling below all major moving averages and underperforming its sector peers.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 February 2026, providing investors with the latest insights into its performance and outlook.